Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Outbreak of Vibrio parahaemolyticus Associated with Consumption of Raw Oysters in Canada, 2015.

Taylor M, Cheng J, Sharma D, Bitzikos O, Gustafson R, Fyfe M, Greve R, Murti M, Stone J, Honish L, Mah V, Punja N, Hexemer A, McIntyre L, Henry B, Kendall P, Atkinson R, Buenaventura E, Martinez-Perez A, Galanis E, Team TOI.

Foodborne Pathog Dis. 2018 Jun 29. doi: 10.1089/fpd.2017.2415. [Epub ahead of print]

PMID:
29958009
2.

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.

Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E.

J Natl Cancer Inst. 2018 May 16. doi: 10.1093/jnci/djy033. [Epub ahead of print]

PMID:
29788332
3.

Surveillance for Lyme disease in Canada: 2009-2015.

Gasmi S, Ogden NH, Lindsay LR, Burns S, Fleming S, Badcock J, Hanan S, Gaulin C, Leblanc MA, Russell C, Nelder M, Hobbs L, Graham-Derham S, Lachance L, Scott AN, Galanis E, Koffi JK.

Can Commun Dis Rep. 2017 Oct 5;43(10):194-199. eCollection 2017 Oct 5.

4.

Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.

Himes BT, Ruff MW, Van Gompel JJ, Park SS, Galanis E, Kaufmann TJ, Uhm JH.

J Neurosurg. 2018 Apr 27:1-5. doi: 10.3171/2017.11.JNS172373. [Epub ahead of print]

PMID:
29701552
5.

Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF.

Neuro Oncol. 2018 Apr 5. doi: 10.1093/neuonc/noy053. [Epub ahead of print]

PMID:
29660006
6.

Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells.

Ohmine S, Salisbury JL, Ingle J, Pettinato G, Haddox CL, Haddad T, Galanis E, Ikeda Y, D'assoro AB.

Oncol Rep. 2018 Apr;39(4):1725-1730. doi: 10.3892/or.2018.6239. Epub 2018 Jan 31.

PMID:
29393405
7.

Outbreak of Escherichia coli O157:H7 Infections Linked to Aged Raw Milk Gouda Cheese, Canada, 2013.

Currie A, Galanis E, Chacon PA, Murray R, Wilcott L, Kirkby P, Honish L, Franklin K, Farber J, Parker R, Shyng S, Sharma D, Tschetter L, Hoang L, Chui L, Pacagnella A, Wong J, Pritchard J, Kerr A, Taylor M, Mah V, Flint J; Investigative Team.

J Food Prot. 2018 Feb;81(2):325-331. doi: 10.4315/0362-028X.JFP-17-283.

PMID:
29369688
8.

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.

Schiff D, Jaeckle KA, Anderson SK, Galanis E, Giannini C, Buckner JC, Stella P, Flynn PJ, Erickson BJ, Schwerkoske JF, Kaluza V, Twohy E, Dancey J, Wright J, Sarkaria JN.

Cancer. 2018 Apr 1;124(7):1455-1463. doi: 10.1002/cncr.31219. Epub 2018 Jan 3.

PMID:
29313954
9.

Associations between extreme precipitation and acute gastro-intestinal illness due to cryptosporidiosis and giardiasis in an urban Canadian drinking water system (1997-2009).

Chhetri BK, Takaro TK, Balshaw R, Otterstatter M, Mak S, Lem M, Zubel M, Lysyshyn M, Clarkson L, Edwards J, Fleury MD, Henderson SB, Galanis E.

J Water Health. 2017 Oct;15(6):898-907. doi: 10.2166/wh.2017.100.

PMID:
29215354
10.

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.

Opyrchal M, Gil M, Salisbury JL, Goetz MP, Suman V, Degnim A, McCubrey J, Haddad T, Iankov I, Kurokawa CB, Shumacher N, Ingle JN, Galanis E, D'Assoro AB.

Oncotarget. 2017 Sep 1;8(53):91803-91816. doi: 10.18632/oncotarget.20610. eCollection 2017 Oct 31.

11.

Evaluation of Agricultural Interventions on Human and Poultry-Related Salmonella Enteritidis in British Columbia.

Taylor M, Cox W, Otterstatter M, de With N, Galanis E.

Foodborne Pathog Dis. 2018 Jan;15(1):39-43. doi: 10.1089/fpd.2017.2302. Epub 2017 Oct 13.

PMID:
29028435
12.

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF.

Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175.

PMID:
29016900
13.

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY; Alliance for Clinical Trials in Oncology and ABTC.

Neuro Oncol. 2018 Mar 27;20(4):546-556. doi: 10.1093/neuonc/nox161.

PMID:
29016887
14.

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.

Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1173-1178. doi: 10.1016/j.ijrobp.2017.07.045. Epub 2017 Aug 5.

PMID:
28939223
15.

State of the art: the evolving role of RT in combined modality therapy for GBM.

Bindra RS, Galanis E, Mehta MP.

J Neurooncol. 2017 Sep;134(3):477-478. doi: 10.1007/s11060-017-2596-4. No abstract available.

PMID:
28913783
16.

Countering the Consequences of Ego Depletion: The Effects of Self-Talk on Selective Attention.

Gregersen J, Hatzigeorgiadis A, Galanis E, Comoutos N, Papaioannou A.

J Sport Exerc Psychol. 2017 Jun 1;39(3):161-171. doi: 10.1123/jsep.2016-0265. Epub 2017 Sep 11.

PMID:
28891370
17.

Remote sensing measurements of sea surface temperature as an indicator of Vibrio parahaemolyticus in oyster meat and human illnesses.

Konrad S, Paduraru P, Romero-Barrios P, Henderson SB, Galanis E.

Environ Health. 2017 Aug 31;16(1):92. doi: 10.1186/s12940-017-0301-x.

18.

Self-talk effectiveness and attention.

Hatzigeorgiadis A, Galanis E.

Curr Opin Psychol. 2017 Aug;16:138-142. doi: 10.1016/j.copsyc.2017.05.014. Epub 2017 Jun 15. Review.

PMID:
28813338
19.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.

PMID:
28687377
20.

Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.

Domingo-Musibay E, Heun JM, Nevala WK, Callstrom M, Atwell T, Galanis E, Erickson LA, Markovic SN.

Oncologist. 2017 Sep;22(9):1026-e93. doi: 10.1634/theoncologist.2017-0060. Epub 2017 Jul 5.

21.

Evaluating the Timeliness of Enteric Disease Surveillance in British Columbia, Canada, 2012-13.

Galanis E, Taylor M, Romanowski K, Bitzikos O, Jeyes J, Nowakowski C, Stone J, Murti M, Paccagnella A, Forsting S, Li S, Hoang L.

Can J Infect Dis Med Microbiol. 2017;2017:9854103. doi: 10.1155/2017/9854103. Epub 2017 Jun 1.

22.

Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.

Paludo J, Fritchie K, Haddox CL, Rose PS, Arndt CAS, Marks RS, Galanis E, Okuno SH, Robinson SI.

Am J Clin Oncol. 2017 Jun 15. doi: 10.1097/COC.0000000000000397. [Epub ahead of print]

PMID:
28622153
23.

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.

Kunos CA, Galanis E, Buchsbaum J, Shi Q, Strauss LC, Coleman CN, Ahmed MM.

J Neurooncol. 2017 Sep;134(3):551-557. doi: 10.1007/s11060-017-2458-0. Epub 2017 May 30. Review.

PMID:
28560665
24.

Searching for clues for eighteen years: Deciphering the ecological determinants of Cryptococcus gattii on Vancouver Island, British Columbia.

Acheson ES, Galanis E, Bartlett K, Mak S, Klinkenberg B.

Med Mycol. 2018 Feb 1;56(2):129-144. doi: 10.1093/mmy/myx037.

PMID:
28525610
25.

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA.

Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029. Review.

26.

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.

Msaouel P, Opyrchal M, Dispenzieri A, Peng KW, Federspiel MJ, Russell SJ, Galanis E.

Curr Cancer Drug Targets. 2018;18(2):177-187. doi: 10.2174/1568009617666170222125035.

PMID:
28228086
27.

Potential and clinical translation of oncolytic measles viruses.

Robinson S, Galanis E.

Expert Opin Biol Ther. 2017 Mar;17(3):353-363. doi: 10.1080/14712598.2017.1288713. Review.

28.

Analysis of enteric disease outbreak metrics, British Columbia Centre for Disease Control, 2005-2014.

Fong D, Otterstatter M, Taylor M, Galanis E.

Can Commun Dis Rep. 2017 Jan 5;43(1):1-6. eCollection 2017 Jan 5.

29.

Where size matters: imaging-based biomarkers for patient stratification.

Erickson BJ, Galanis E.

Neuro Oncol. 2017 Jan;19(1):7-8. doi: 10.1093/neuonc/now248. No abstract available.

30.

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.

Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM.

J Clin Oncol. 2017 Jan 20;35(3):361-369. doi: 10.1200/JCO.2016.70.7562. Epub 2016 Nov 28. Review.

PMID:
27893327
31.

Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.

Kurokawa C, Geekiyanage H, Allen C, Iankov I, Schroeder M, Carlson B, Bakken K, Sarkaria J, Ecsedy JA, D'Assoro A, Friday B, Galanis E.

J Neurooncol. 2017 Jan;131(1):41-48. doi: 10.1007/s11060-016-2285-8. Epub 2016 Nov 5.

32.

Leptomeningeal metastases of solid cancer.

Le Rhun E, Galanis E.

Curr Opin Neurol. 2016 Dec;29(6):797-805. Review.

PMID:
27661208
33.

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.

Hardcastle J, Mills L, Malo CS, Jin F, Kurokawa C, Geekiyanage H, Schroeder M, Sarkaria J, Johnson AJ, Galanis E.

Neuro Oncol. 2017 Apr 1;19(4):493-502. doi: 10.1093/neuonc/now179.

34.

Applied Nanotechnology and Nanoscience in Orthopedic Oncology.

Savvidou OD, Bolia IK, Chloros GD, Goumenos SD, Sakellariou VI, Galanis EC, Papagelopoulos PJ.

Orthopedics. 2016 Sep 1;39(5):280-6. doi: 10.3928/01477447-20160823-03. Review.

PMID:
27636683
35.

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Geekiyanage H, Galanis E.

Mol Oncol. 2016 Nov;10(9):1387-1403. doi: 10.1016/j.molonc.2016.07.007. Epub 2016 Jul 28.

36.

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

JAMA. 2016 Jul 26;316(4):401-9. doi: 10.1001/jama.2016.9839.

37.

Utility of algorithms for the analysis of integrated Salmonella surveillance data.

Vrbova L, Patrick DM, Stephen C, Robertson C, Koehoorn M, Parmley EJ, DE With NI, Galanis E.

Epidemiol Infect. 2016 Jul;144(10):2165-75. doi: 10.1017/S0950268816000182.

PMID:
27324462
38.

Glioblastoma.

Wirsching HG, Galanis E, Weller M.

Handb Clin Neurol. 2016;134:381-97. doi: 10.1016/B978-0-12-802997-8.00023-2. Review.

PMID:
26948367
39.

Are enteric infections sexually transmitted in British Columbia?

Narayan S, Galanis E; BC STEI Group.

Can Commun Dis Rep. 2016 Feb 4;42(2):24-29. eCollection 2016 Feb 4.

40.

Aurora-A Kinase as a Promising Therapeutic Target in Cancer.

D'Assoro AB, Haddad T, Galanis E.

Front Oncol. 2016 Jan 6;5:295. doi: 10.3389/fonc.2015.00295. eCollection 2015. Review.

41.

Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).

Brown PD, Anderson SK, Carrero XW, O'Neill BP, Giannini C, Galanis E, Shah SA, Abrams RA, Curran WJ Jr, Buckner JC, Shaw EG.

Neurooncol Pract. 2015 Dec;2(4):199-204. Epub 2015 Aug 6.

42.

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

Baldo A, Galanis E, Tangy F, Herman P.

Hum Vaccin Immunother. 2016 May 3;12(5):1102-16. doi: 10.1080/21645515.2015.1122146. Epub 2015 Dec 2. Review.

43.

What next for newly diagnosed glioblastoma?

Domingo-Musibay E, Galanis E.

Future Oncol. 2015;11(24):3273-83. doi: 10.2217/fon.15.258. Epub 2015 Nov 12. Review.

44.

Enteric outbreak surveillance in British Columbia, 2009-2013.

Taylor M, Galanis E; BC Enteric Outbreak Summary Working Group, Forsting S, Gustafson L, Ip J; Jeyes J, Lem M, Murti M, Nowakowski C, Ritson M, Stone J, Tone G.

Can Commun Dis Rep. 2015 Nov 5;41(11):263-271. eCollection 2015 Nov 5.

45.

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.

Huang RY, Rahman R, Ballman KV, Felten SJ, Anderson SK, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY.

Clin Cancer Res. 2016 Feb 1;22(3):575-81. doi: 10.1158/1078-0432.CCR-14-3040. Epub 2015 Oct 21.

46.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.

Iankov ID, Kurokawa CB, D'Assoro AB, Ingle JN, Domingo-Musibay E, Allen C, Crosby CM, Nair AA, Liu MC, Aderca I, Federspiel MJ, Galanis E.

Cancer Gene Ther. 2015 Sep;22(9):438-44. doi: 10.1038/cgt.2015.36. Epub 2015 Aug 14.

47.

Multi-Province Listeriosis Outbreak Linked to Contaminated Deli Meat Consumed Primarily in Institutional Settings, Canada, 2008.

Currie A, Farber JM, Nadon C, Sharma D, Whitfield Y, Gaulin C, Galanis E, Bekal S, Flint J, Tschetter L, Pagotto F, Lee B, Jamieson F, Badiani T, MacDonald D, Ellis A, May-Hadford J, McCormick R, Savelli C, Middleton D, Allen V, Tremblay FW, MacDougall L, Hoang L, Shyng S, Everett D, Chui L, Louie M, Bangura H, Levett PN, Wilkinson K, Wylie J, Reid J, Major B, Engel D, Douey D, Huszczynski G, Di Lecci J, Strazds J, Rousseau J, Ma K, Isaac L, Sierpinska U.

Foodborne Pathog Dis. 2015 Aug;12(8):645-52. doi: 10.1089/fpd.2015.1939. Epub 2015 Jun 3.

PMID:
26258258
48.

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee.

Neuro Oncol. 2015 Sep;17(9):1188-98. doi: 10.1093/neuonc/nov095. Epub 2015 Aug 5. Review.

49.

Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.

Berg AK, Buckner JC, Galanis E, Jaeckle KA, Ames MM, Reid JM.

J Clin Pharmacol. 2015 Nov;55(11):1303-12. doi: 10.1002/jcph.543. Epub 2015 Jun 26.

50.

Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.

Phillips P, Galanis E, MacDougall L, Chong MY, Balshaw R, Cook VJ, Bowie W, Steiner T, Hoang L, Morshed M, Ghesquiere W, Forrest DM, Roscoe D, Doyle P, Kibsey PC, Connolly T, Mirzanejad Y, Thompson D; British Columbia Cryptococcus gattii Study Group.

Clin Infect Dis. 2015 May 1;60(9):1368-76. doi: 10.1093/cid/civ041. Epub 2015 Jan 28.

PMID:
25632012

Supplemental Content

Loading ...
Support Center